NorthWest Biotherapeutics Inc (NWBO)

[Investor082]

Balanced perspective. I agree UK approval is pretty much a done deal. However, it’s what comes next (significant non dilutive funding) that will determine the long term direction of the share price. Otherwise we give up whatever gains we get at UK approval.

My bet is that LP will disappoint again. So UK approval may be the best chance to get out before significant dilution takes over again for the next couple of years.